✦ LIBER ✦

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

✍ Scribed by Matsumura, Y.

Book ID: 127122354
Publisher: Oxford University Press
Year: 2004
Tongue: English
Weight: 159 KB
Volume: 15
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdh092

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized trial of doxorubic

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

✍ A Bensalem, K Bouzid 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 618 KB

Phase II trial and pharmacokinetic study

Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer

✍ Lissandra Dal Lago; Marc F. Richter; Anna I. Cancela; Sabrina A. Fernandes; Keyl 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 82 KB

Phase I study of Tomudex and Doxorubicin

Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)

✍ Georg A. Bjarnason; Danielle Charpentier; Ralph Wong; Rakesh Goel; Lynn Douglas; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 62 KB

Phase I/II Pharmacokinetic Study of Peme

Phase I/II Pharmacokinetic Study of Pemetrexed and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer

✍ Robert Paridaens; Luc Dirix; Herlinde Dumez; Annemie Prové; Hans Wildiers; Ana A 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

Phase I dose escalation and pharmacokine

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

✍ Danson, S; Ferry, D; Alakhov, V; Margison, J; Kerr, D; Jowle, D; Brampton, M; Ha 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A Phase I and pharmacokinetic study of h

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r